Global Custom Market Research Reports Provider Company


Immune Pharmaceuticals Inc (IMNP) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The companys bertilimumab is under clinical development for moderate to severe ulcerative colitis, crohns disease and bullous pemphigoid. It also offers nanomabs, which is an antibody nanoparticle conjugate technology platform for the targeted delivery of chemotherapeutics. Immune Pharmas crolibulin is a small molecule vascular disrupting agent that is used for the treatment of solid tumors. The company develops drugs in the areas of immuno oncology, nano-dermatology and neuropathic pain. It has research and development facility in Herzliya-Pituach, Israel. Immune Pharma is headquartered in New York, the US.

Immune Pharmaceuticals Inc Key Recent Developments

Aug 28,2017: Immune Pharmaceuticals Provides Business Update and Summary of Recent Financial Highlights
Aug 14,2017: Immune Pharmaceuticals appoints Tony Fiorino, MD, PhD as Chief Medical Officer and Chief Operating Officer
Aug 14,2017: Immune Pharmaceuticals Appoints Tony Fiorino, MD, PhD as Chief Medical Officer and Chief Operating Officer
Aug 04,2017: Immune Pharmaceuticals Issues Letter to Shareholders
Jul 19,2017: Immune Pharmaceuticals Provides Update on Plan to Implement a Spin-off of Cytovia into a Separate Publicly Traded Oncology Company

This comprehensive SWOT profile of Immune Pharmaceuticals Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immune Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents

Section 1 - About the Company

Immune Pharmaceuticals Inc - Key Information

Immune Pharmaceuticals Inc - Overview

Immune Pharmaceuticals Inc - Key Employees

Immune Pharmaceuticals Inc - Key Employee Biographies

Immune Pharmaceuticals Inc - Key Operational Heads

Immune Pharmaceuticals Inc - Major Products and Services

Immune Pharmaceuticals Inc - History

Immune Pharmaceuticals Inc - Company Statement

Immune Pharmaceuticals Inc - Locations And Subsidiaries

Immune Pharmaceuticals Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Immune Pharmaceuticals Inc - Business Description

Immune Pharmaceuticals Inc - Corporate Strategy

Immune Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Immune Pharmaceuticals Inc - Strengths

Immune Pharmaceuticals Inc - Weaknesses

Immune Pharmaceuticals Inc - Opportunities

Immune Pharmaceuticals Inc - Threats

Immune Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Immune Pharmaceuticals Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

Immune Pharmaceuticals Inc, Key Information

Immune Pharmaceuticals Inc, Key Ratios

Immune Pharmaceuticals Inc, Share Data

Immune Pharmaceuticals Inc, Major Products and Services

Immune Pharmaceuticals Inc, History

Immune Pharmaceuticals Inc, Key Employees

Immune Pharmaceuticals Inc, Key Employee Biographies

Immune Pharmaceuticals Inc, Key Operational Heads

Immune Pharmaceuticals Inc, Other Locations

Immune Pharmaceuticals Inc, Subsidiaries

Immune Pharmaceuticals Inc, Key Manufacturing facilities

Immune Pharmaceuticals Inc, Key Competitors

Immune Pharmaceuticals Inc, SWOT Analysis

Immune Pharmaceuticals Inc, Ratios based on current share price

Immune Pharmaceuticals Inc, Annual Ratios

Immune Pharmaceuticals Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures

Immune Pharmaceuticals Inc, Performance Chart

Immune Pharmaceuticals Inc, Ratio Charts

Market Outline: Autoimmune Disease Diagnostics Market The immune system protects the body from infections and diseases. In autoimmune disorders low or overactivity of immune system may appear. There is no exact

View Report

Calimmune Inc (Calimmune) is a clinical-stage biotechnology company that focuses on the development of novel gene therapies that have the capability to enhance the immune systems of individuals from chronic

View Report

CytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company that discovers, develops, and commercializes tumor-targeted therapies for the treatment of cancer. The company develops nanotherapy platform, Aurimune, a tumor-targeted

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports